参考文献/References:
[1]晏俊芳,于浪,孙玉亮,等.以CT图像为基础的宫颈癌三维腔内放疗[J].中华放射肿瘤学杂志,2014,23(5):377-381.[2]张宁,赵志鹏,程光惠,等.局部晚期宫颈癌腔内联合组织间插植3D-IGBT的剂量学研究[J].中华放射肿瘤学杂志,2015,24(3):267-270.[3]陈静,丁乾,罗鸣,等.宫颈癌调强放射治疗的临床研究[J].华中科技大学学报(医学版),2015,41(3):353-357.[4]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.[5]贾彦召,余杰,饶石磊.宫颈癌三维适形放疗与二维放疗计划的比较分析[J].中国实用医药,2015,10（5）:61-62.[6]Patankar SS,Tergas AI,Deutsch I,et al.High versus low-dose rate brachytherapy for cervical cancer[J].Gynecol Oncol,2015,136(3):534-541.[7]刘培培,曹永珍.容积旋转调强与固定野调强在宫颈癌根治性放疗中的剂量学比较[J].中国辐射卫生,2015,24(2):109-112.[8]王承伟,冯志俊,徐惠,等.宫颈癌ＶＭＲＴ与常规４野放疗中的剂量学比较及近期疗效观察[J].江苏大学学报,2015,25(4):322-325.[9]张基永,林珠,吴丽丽,等.图像引导的自适应放疗在宫颈癌治疗中的应用[J].山东医药,2015,55(27):38-39.[10]毛世华,张涛,谈宗国,等.178例宫颈癌放疗疗效及预后相关因素分析[J].实用癌症杂志,2014,29(7):829-831.[11]Mazeron R,Castelnau-Marchand P,Escande A,et al.Tumor dose-volume response in imageguided adaptive brachytherapy for cervical cancer:A meta-regression analysis[J].Brachytherapy,2016,15(5):537-542.[12]陈艳,廖妮红,黄雪芳,等.顺铂联合多西他赛同步放化疗治疗中晚期宫颈癌的临床观察[J].实用癌症杂志,2014,29(6):699-701.[13]齐曼,宋冀,郑艳杰.调强放疗与三维适形放疗治疗局部晚期宫颈癌的临床疗效及毒副作用观察[J].实用癌症杂志,2015,30(5):698-700.[14]阴骏,李鹏程,范子煊,等.局部晚期宫颈癌自适应放疗剂量学及生存分析与毒性反应评价[J].肿瘤预防与治疗,2017,44(4):236-238.[15]金红艳,刘倩,葛四平,等.尼妥珠单抗联合调强放疗及周期化疗治疗局部晚期宫颈癌的临床观察[J].实用癌症杂志,2017,32(3):461-463.[16]Ghorbani M,Hashempour M,Azizi M,et al.Evaluating the effect of various intracavitary applicators on dosimetric parameters of (192)Ir, (137)Cs, and (60)Co sources[J].Australas Phys Eng Sci Med,2016,39(2):477-491. [17]梁克,何少琴,冯炎. 快中子及X射线诱导人食管癌细胞凋亡的研究[J]. 中华放射肿瘤学杂志,2000,9(1):38. [18]孙小梅,丁丽娟,董丽华,等.容积旋转调强与固定野调强在晚期宫颈癌放疗的剂量学比较及疗效观察[J].中华放射医学与防护杂志,2016,36(7):509-512.[19]Tuntipumiamorn L,Lohasammakul S,Dankulchai P,et al.Comparison of impact of target delineation of computed tomography-and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer[J].J Contemp Brachytherapy,2018,10(5):418-424.[20]王嘉琪,李静,宋海涛.调强放疗与三维适形放疗联合腔内后装放疗治疗中晚期宫颈癌的对比研究[J].实用临床医药杂志,2015,19(17):67-70.[21]刘艳,张洁,佐合拉古丽·木塔力甫,等.宫颈癌常规放疗与图像引导的调强放疗近期并发症及疗效的对比[J].实用医学杂志,2016,32(2):211-214.[22]薛涛,刘光波,袁香坤,等. 宫颈癌近距离腔内放射治疗中膀胱和直肠ICRU参考点剂量和体积剂量受量比较[J]. 中国医学物理学杂志,2017,34(9):897-901. [23]栾朝辉,宋梅,于娟,等.调强放疗与三维适形放疗治疗老年中晚期宫颈癌的疗效观察[J].中华老年医学杂志,2016,35(10):1103-1106.[24]余进进,商文庆,董春林.调强放疗联合腔内后装治疗中晚期宫颈癌的临床疗效[J].江苏医药,2016,42(16):1814-1816.[25]高汝斌,仇红,辛红梅.手足软组织良性肿瘤MRI分析[J]. 实用放射学杂志,2016,32(6):982-984. [26]邓小丽.DCe-MRI定量分析在软组织肿瘤的应用价值初步研究[D].大连医科大学,2016.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(10):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Medical Information,2018,31(10):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[3]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(10):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[4]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(10):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[5]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(10):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[6]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(10):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[7]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[8]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Medical Information,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[9]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(10):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[10]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(10):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[11]张 慧.宫颈癌放化疗的选择[J].医学信息,2021,34(11):66.[doi:10.3969/j.issn.1006-1959.2021.11.020]
ZHANG Hui.Choice of Radiotherapy and Chemotherapy for Cervical Cancer[J].Medical Information,2021,34(10):66.[doi:10.3969/j.issn.1006-1959.2021.11.020]